DNA impurities in a composition comprising a parvoviral virion
AssigneeuniQure IP B.V.
InventorsJacek Lubelski, Wilhelmus Theodorus Johannes Maria Christiaan Hermens
Life of this patent
Estimating the term…
Abstract
The current invention relates to nucleic acid impurities in a composition comprising a parvoviral vector. In particular, the current invention shows that DNA impurities are not randomly encapsulated within a parvoviral virion. The invention therefore relates to a method for identifying and quantifying a nucleic acid impurity in a composition comprising a parvoviral vector. Finally, the current invention relates to method of determining whether a composition comprising a parvoviral vector is regarded as clinically pure.
Claims11
A method for identifying and quantifying a nucleic acid impurity in a composition comprising a parvoviral vector, comprising:
- (a) subjecting the composition to nucleic acid sequencing to obtain at least a thousand random reads of nucleotide sequences;
- (b) comparing, using a processor, the at least a thousand random reads from step (a) with a nucleotide sequence of a biological component used in a process for producing the composition, whereby a match between a random read and a nucleotide sequence of a biological component identifies a nucleic acid impurity;
- (c) determining an average number of reads per parvoviral vector;
- (d) determining a distribution of reads by calculating a number of reads per nucleotide of an identified nucleic acid impurity;
- wherein an identified nucleic acid impurity is identified as an overrepresented impurity when the distribution of reads is not random and the number of reads per nucleotide of a nucleic acid impurity is at least 0.001% the average number of reads per parvoviral vector.
Dependencies are inferred from the claim text.